OneOncology - APP Onboarding Program (On-Demand)

Oncology 101:  A Hematology and Oncology Primer for Advanced Practice Providers - (On-Demand) Fall - 2023"

The demand for cancer care is expected to grow 40% over the next six years and ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of patients, advanced practice providers (APPs), whose education and training is focused on health promotion, disease prevention, and primary care medical management, have increasingly been sought to filled the shortage. However, many APPs have little background or training in oncology. As a result, oncology practices need to provide new staff with an onboarding program that helps to establish a working baseline level of knowledge of hematology and oncology.

To help APPs prepare for a new career in the specialty of oncology, Horizon CME has developed “Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers”. In this on-demand program with updates and content from the Fall 2023 virtual Oncology 101 conference, clinicians will gain a basic understanding of cancer therapies, benign and malignant hematologic disorders, solid malignancies, supportive care strategies, oncologic emergencies, genetics and molecular testing, and more. Participation in this program will provide APPs with the foundational knowledge they need to provide support and care to cancer patients as part of the multidisciplinary oncology care team. 

 

LEARNING OBJECTIVES:

Upon completion of this activity, participants should be better able to: 

1. Describe the presentation, evaluation, and treatment of common solid and hematologic malignancies

2. Recognize the presentation, evaluation, and treatment of common benign hematologic disorders 

3. Summarize the role of genetics and molecular testing in cancer care 

4. Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy

5. Identify and appropriately manage common oncologic emergencies

6. Outline the role of survivorship and effectively incorporate it into oncology practice

 

TARGET AUDIENCE:

This program is appropriate for new APPs, nurses, and pharmacists in oncology, clinicians seeking a review, or clinicians considering a career in oncology. 

Commercial Support: Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers - On-Demand - Fall 2023 is supported in part by independent medical educational grants from Novocure, Inc., Merck Sharp & Dohme Corp., and Bristol Myers Squibb Company.

 

Presented By:  

    

Course summary
Available credit: 
  • 17.50 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 17.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 17.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 17.50 credit.
  • 3.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 3.25 credit.
Course opens: 
01/15/2024
Course expires: 
05/31/2025
Cost:
$125.00
Rating: 
0

Planning Committee

 

Beth Faiman, PHD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner

Department of Hematology and Medical Oncology Cleveland Clinic

Cleveland, OH

 

Beth Sandy, MSN, CRNP

Nurse Practitioner, Thoracic Medical Oncology

Abramson Cancer Center, University of Pennsylvania

Philadelphia, PA

 

Val R. Adams, PharmD, FCCP, FHOPA, BCOP

Associate Professor, Oncology Specialist

University of Kentucky

Lexington, KY

 

Faculty

 

Justin Baker, MD

Chief, Division of Quality of Life and Palliative Care

St. Jude Children's Research Hospital

Memphis, TN

 

Marianne Davies, DNP, ACNP, AOCNP, FAAN

Nurse Practitioner

Yale Comprehensive Cancer Center

New Haven, CT

 

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

Associate Clinical Professor

University of California San Francisco

Hematology/Oncology Nurse Practitioner

San Francisco, CA

 

Jennie M. Goble, PA-C

Instructor in Medicine

 Mayo Clinic

 Rochester, MN

 

Jamie Carroll APRN, CNP, MSN

Nurse Practitioner

Mayo Clinic

Rochester, MN

 

Matthew Robinson DO, MS

Attending Physician

Associate Medical Director of Hospice Baptist Memorial Hospital 

Memphis, TN

 

Lauren Imboden, MMS, PA-C

Physician Assistant

Atrium Health Wake Forest Baptist

Winston Salem, NC

 

Ellen Marin, PA-C

Physician Assistant

Winship Cancer Institute of Emory University

Atlanta, GA

 

Linda M. Perry, MS, PA-C

Physician Assistant

Perelman Center for Advanced Medicine

Philadelphia, PA

 

Meredith Beaton, MSN, RN, AG-ACNP

Nurse Practitioner

UCHealth Anschutz

Aurora, CO

 

Korie Bigbee DNP

Nurse Practitioner Specialist

Kaiser Permanente at City of Hope

 Duarte CA

 

Kathleen Boyle, DScPAS, PA-C 

Physician Assistant

Dana-Farber Cancer Institute

Boston, MA

 

Heather Koniarczyk, MSN, APRN-CNP, AOCNP

Adult Nurse Practitioner

Cleveland Clinic -Taussig Cancer Institute

Cleveland, OH

 

Jessica Walchonski, PA-C

Physician Assistant

UCLA Health

Los Angeles, CA

 

Grace Baek, PharmD, BCOP

Clinical Pharmacist, Hematology/Oncology

Fred Hutchinson Cancer Center

Seattle, WA

 

Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP

Clinical Oncology Pharmacist

University of Illinois College of Pharmacy

Chicago, IL

 

Jennifer Murphy, PharmD, BCOP

Senior Pharmacist

UCD Health, Oncology, and Investigational Drug Service

San Francisco, CA

 

Laura Wood, RN, MSN, OCN 

Nurse

Cleveland Clinic, Taussig Cancer Center

Cleveland, OH

 

Michael Lai, ARNP

Nurse Practitioner

Fred Hutchinson Cancer Center

Seattle, WA

 

Lisa Nodzon PhD, APRN, AOCNP

Nurse Practitioner

H. Lee Moffitt Cancer Center and Research Institute

Tampa, FL

 

Patricia Mangan, RN, MSN, CRNP

Nurse Lead, Hematologic Malignancies Program

Abramson Cancer Center,

University of Pennsylvania

Philadelphia, PA

 

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

 

Faculty, Authors, and Content Developers Disclosures:

  • Laura J. Zitella, MS, RN, ACNP-BC, AOCN discloses Speaker's Bureau with Abbvie but that relationship has ended with during the past 24 months.
  • Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Board and Consulting Fee with Janssen, Sanofi, Karyopharm during the past 24 months.
  • Beth Sandy, MSN, CRNP discloses Speaker's Bureau with Lilly, Amgen, AstraZeneca, Takeda, Jazz, Merck and Consulting Fee with Janssen during the past 24 months.
  •  Lisa Nodzon PhD, APRN, AOCNP discloses Speaker's Bureau with Pharmacyclics AstraZeneca and Speaker's Bureau with Takeda and Genentech/AbbVie but that relationship has ended.Advisory Board with BeiGene; Pharmacyclics, Novartis and Consulting Fee with AstraZeneca; AbbVie during the past 24 months.
  • Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP discloses Speaker's Bureau with Mirati and Advisory Boards with Genentech during the past 24 months.
  • Lauren Imboden, PA-C discloses Speaker's Bureau with Sobi and Advisory Boards with Sanofi during the past 24 months.
  • Linda M. Perry, MS, PA-C discloses Speaker's Bureau with Incyte and Advisory Board with Incyte and Sanofi during the past 24 months.
  • Patricia Mangan, RN, MSN, CRNP discloses Speaker's Bureau and Advisory Boards with BMS and Janssen but that relationship has ended during the past 24 months.
  • Matthew Robinson, DO, MS discloses contracted research with American Osteopathic Association during the past 24 months.
  • Jamie Carroll, APRN, CNP, MSN discloses Advisory Board Pfizer, Novartis, Sermonix, Eli Lilly, AstraZeneca and Consulting Fee with Research to practice but all of these relationships have ended during the past 24 months.
  • Jessica Walchonski, PA-C discloses Advisory Boards with Immunogen but that relationship has ended during the past 24 months.
  • Jennifer Murphy, PharmD, BCOP discloses Speaker's Bureau with McCreadie but that relationship has ended and Ownership interest with AbbVie, Moderna during the past 24 months.
  • Laura S. Wood, RN, MSN, OCN discloses Speaker's Bureau with AVEO, BMS, EMD Serono, Exelixis, Merck, Pfizer during the past 24 months.
  • Michael Lai, ARNP discloses Advisory Boards with Janssen, Bayer, Astellas, Seagen but these relationships have ended during the past 24 months.

Planners:

  • Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses Advisory Board and Consulting Fee with Janssen, Sanofi, Karyopharm during the past 24 months.
  • Beth Sandy, MSN, CRNP discloses Speaker's Bureau with Lilly, Amgen, AstraZeneca, Takeda, Jazz, Merck and Consulting Fee with Janssen during the past 24 months
  • Val R. Adams, PharmD, FCCP, FHOPA, BCOP discloses the following relevant financial relationships: Regeneron and BMS.

Available Credit

  • 17.50 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 17.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 17.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 17.50 credit.
  • 3.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 3.25 credit.

Price

Cost:
$125.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above